Description: CohBar Inc is a research stage biotechnology company. The Company conducts investigational research into Mitochondrial-Derived Peptides to evaluate their therapeutic potential through in vitro and in vivo models.
Home Page: www.cohbar.com
CWBR Technical Analysis
1455 Adams Drive
Menlo Park,
CA
94025
United States
Phone:
650 446 7888
Officers
| Name | Title |
|---|---|
| Dr. Joseph J. Sarret J.D., M.D. | CEO & Director |
| Dr. Pinchas Cohen Dean, M.D. | Founder & Member of Scientific Advisory Board |
| Dr. Nir Yacov Barzilai M.D. | Founder & Member of Scientific Advisory Board |
| Prof. John M. Amatruda M.D., Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| Mr. Jeffrey F. Biunno CPA, CPA, M.B.A., MBA | CFO, Treasurer & Sec. |
| Ms. Jordyn Tarazi | Director of Investor Relations |
| Dr. Kent Grindstaff Ph.D. | Sr. VP of Research |
| Dr. Nick Vlahakis MBBS | Acting Chief Medical Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.2652 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2015-01-28 |
| Fiscal Year End: | December |
| Full Time Employees: | 9 |